###begin article-title 0
###xml 20 40 20 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 20 39 <span type="species:ncbi:210">Helicobacter pylori</span>
Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
###end article-title 0
###begin p 1
Conflict of interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background: </bold>
###xml 101 120 101 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 122 131 122 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 232 239 232 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 101 120 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 122 131 <span type="species:ncbi:210">H. pylori</span>
Background: Lansoprazole, amoxicillin, and clarithromycin are commonly used drugs for eradication of Helicobacter pylori (H. pylori). A few studies reported that the eradication rate was influenced by the functional polymorphism of CYP2C19, whose product metabolizes proton pomp inhibitors including lansoprazole.
###end p 2
###begin p 3
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods: </bold>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*1</italic>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*2 </italic>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*3</italic>
###xml 418 430 418 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*2*2, *2*3, </italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*3*3</italic>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681G</italic>
###xml 497 499 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1</italic>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681A</italic>
###xml 512 515 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> *2</italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636G</italic>
###xml 537 539 537 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1</italic>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636A</italic>
###xml 553 555 553 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*3</italic>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 59 71 <span type="species:ncbi:9606">participants</span>
###xml 186 198 <span type="species:ncbi:9606">participants</span>
Methods: This study examined the eradication rate among 67 participants in the polymorphism study who visited Daiko Medical Center, Nagoya University from July 2004 to October 2005. The participants aged 20 to 69 years were classified into three group according to CYP2C19 genotype; rapid metabolizers (RM) with *1*1 genotype, intermediate metabolizers (IM) with *1*2 or *1*3 genotype, and poor metabolizers (PM) with *2*2, *2*3, or *3*3 genotype. For the genotype classification, G681A (681G for *1 and 681A for *2) and G636A (636G for *1 and 636A for *3) were genotyped by PCR with confronting two-pair primers (PCR-CTPP). They were also genotyped for IL-1B T-31C and TNF-A T-1031C by a duplex PCR-CTPP.
###end p 3
###begin p 4
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results: </bold>
###xml 217 228 217 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B -31CC</italic>
###xml 284 285 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 343 344 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 377 382 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 488 496 484 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A CT</italic>
###xml 534 536 530 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
Results: The eradication rate was 70.0% for RM, 93.9% for IM, and 85.7% for PM. The difference in the rate between RM and IM+PM was statistically significant (p=0.025). The eradication rate was highest for those with IL-1B -31CC; the p value was marginal among the whole subjects (chi2=3.78, p=0.05) and not significant among the RM group (chi2=1.60, p=0.21). The genotypes of TNF-A T-1031C had no associations with the eradication rate. But among the RM group, the odd ratio (OR) of the TNF-A CT for the eradication rate relative to TT was marginally reduced (OR=0.05, 95% confidence interval, 0.002-1.19).
###end p 4
###begin p 5
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions</bold>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 327 339 327 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A -1031C</italic>
Conclusions: The present study confirmed the low eradication rate for RM. The reproduced finding provides evidence that the CYP2C19 genotype is useful to predict the success of the treatment. For the RM group, alternative regimens expected to be with a higher eradication rate will be recommended, especially to those with the TNF-A -1031C allele.
###end p 5
###begin title 6
1. Introduction
###end title 6
###begin p 7
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 226 235 226 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 499 508 499 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 763 772 763 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 21 30 <span type="species:ncbi:210">H. pylori</span>
###xml 226 235 <span type="species:ncbi:210">H. pylori</span>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
###xml 499 508 <span type="species:ncbi:210">H. pylori</span>
###xml 646 649 <span type="species:ncbi:9606">men</span>
###xml 654 659 <span type="species:ncbi:9606">women</span>
###xml 742 747 <span type="species:ncbi:9606">women</span>
###xml 763 772 <span type="species:ncbi:210">H. pylori</span>
Helicobacter pylori (H. pylori) infection is an established cause of digestive diseases including ulcer, atrophic gastritis, stomach cancer, and mucosa-associated lymphoid tissue lymphoma 1-3. Recent studies demonstrated that H. pylori eradication caused increase in platelets of patients with idiopathic thrombocytopenic purpura (ITP) 4,5. Another study reported that the eradication may be useful to treatment of chronic urticaria, an autoimmune disease 6. Arteriosclerosis is also presumed to be H. pylori -associated disease, though there is still controversy 7. A study reported that infertility was associated with the seropositivity among men and women. In addition, they showed biological evidence that follicular fluid from infected women contained anti-H. pylori antibody, which reacted with spermatozoa 8.
###end p 7
###begin p 8
###xml 34 43 34 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 357 366 357 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 737 746 737 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1020 1029 1020 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 34 43 <span type="species:ncbi:210">H. pylori</span>
###xml 357 366 <span type="species:ncbi:210">H. pylori</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 737 746 <span type="species:ncbi:210">H. pylori</span>
###xml 1020 1029 <span type="species:ncbi:210">H. pylori</span>
In Japan, health insurance covers H. pylori tests and eradication treatment for digestive ulcers, but not for the other diseases. Since are convinced the effect of the eradication on ITP treatment and the possibility of stomach cancer prevention at least among those who are successfully treated for early stomach cancer 9, there are increasing demands for H. pylori eradication treatment in Japan. In an international workshop held in Sweden, "the majority of the scientific task force favored a search-and-treat strategy in first-degree relatives of gastric cancer patients and an overwhelming majority felt that a more general screen-and-treat strategy should be focused in the first instance on a population with a high incidence of H. pylori-associated diseases" 10, which may include Japan, a high stomach cancer incidence country. The eradication was reported to be effective to reduce the medical care costs in the United Kingdom 11, and in Japan 12. These expert recommendations/opinions may partly justify the H. pylori eradication for the more generalized populations in Japan.
###end p 8
###begin p 9
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 630 637 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 680 687 680 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 766 775 766 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 925 932 925 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 993 1000 993 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 1005 1011 1005 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1112 1118 1112 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-511TT</italic>
###xml 1131 1136 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 1281 1287 1278 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-511CC</italic>
###xml 1297 1299 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 23 32 <span type="species:ncbi:210">H. pylori</span>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
###xml 766 775 <span type="species:ncbi:210">H. pylori</span>
The treatments against H. pylori infection approved in Japanese health insurance are 7-day triple therapies of lansoprazole (60mg) + amoxicillin (1,500mg) + clarithromycin (400mg) and omeprazole (40mg) + amoxicillin (1,500mg) + clarithromycin (800mg). The reported eradication rate for the former treatment was 87.5% in 96 patients with gastric ulcer and 91.1% in 90 patients with duodenal ulcer 13. The rate for the latter treatment was reported to be 78.8% (n=113) by Kuwayama et al at the 7th annual scientific meeting of the Japanese Society of Helicobacter Research 2001. Since lansoprazole and omeprazole are metabolized by CYP2C19 in the liver, the functional genotypes of CYP2C19 could influence the eradication rate, as well as clarithromycin resistance of H. pylori. Concerning the lansoprazole-based triple therapy, there are two studies reporting the significant difference in the rate among those with different CYP2C19 genotypes 14 or with the different genotype combinations of CYP2C19 and IL-1B 15, while other studies showed no significant association 16,17. It was reported that those with the -511TT genotype of IL-1B encoding interleukin 1beta, a potent gastric acid inhibiting proinflammatory cytokine, had a higher eradication rate relative to those with the -511CC genotype 18.
###end p 9
###begin p 10
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 230 235 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 306 308 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 362 367 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 408 414 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A </italic>
###xml 654 663 646 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 722 735 714 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A -1031CC</italic>
###xml 740 750 732 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 777 779 769 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 849 851 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 654 663 <span type="species:ncbi:210">H. pylori</span>
###xml 740 749 <span type="species:ncbi:210">H. pylori</span>
This study aimed to examine the associations of the eradication rate with the functional polymorphisms of CYP2C19 G681A (*2) and G636A (*3), IL-1B T-31C tightly linked with C-511T 19, and TNF-A T-1031C. Since TNF-alpha encoded by TNF-A, is also a proinflammatory cytokine inhibiting gastric acid secretion 20, we hypothesized that the functional polymorphism of TNF-A may influence the eradication rate. The TNF-A gene encoding TNF-alpha is known to have five polymorphism in the promoter region; G-238A, G-308A, C-857T, C-863A, and T-1031C. Among Japanese, the -238A and -308A alleles are rare and C-863A is tightly linked with T-1031C. With respect to H. pylori seroposotivity, we have reported that the decreased OR of TNF-A -1031CC for H. pylori seropositivity relative to TT was significant, but the association with C-857T was not significant 21.
###end p 10
###begin p 11
This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (approval number 155) on June 16, 2004.
###end p 11
###begin title 12
2. Subjects and methods
###end title 12
###begin title 13
Study subjects
###end title 13
###begin p 14
###xml 104 113 104 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 104 113 <span type="species:ncbi:210">H. pylori</span>
###xml 494 506 <span type="species:ncbi:9606">participants</span>
Subjects were sampled from those visited Daiko Medical Center, Nagoya University, Nagoya, Japan to seek H. pylori tests and eradication between July 2004 and October 2005. The visitors aged 20 to 69 years were asked to participate in the polymorphism study. Those who agreed with a written informed consent form to provide a 7ml of blood sample and to answer a questionnaire form on lifestyle including smoking habit, were enrolled in the present study. Any genotypes were not disclosed to the participants. The study protocol was approved by the ethics committee of the Nagoya University Graduate School of Medicine.
###end p 14
###begin title 15
###xml 14 23 <span type="species:ncbi:210">H. pylori</span>
Treatment for H. pylori infection
###end title 15
###begin p 16
###xml 158 167 158 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 208 217 208 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 272 274 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 158 167 <span type="species:ncbi:210">H. pylori</span>
###xml 208 217 <span type="species:ncbi:210">H. pylori</span>
Lansoprazole (30mg), amoxicillin (750mg), and clarithromycin (200mg) twice a day for 7 days (LAC regimen) were prescribed for those found to be infected with H. pylori by a 13C-urea breath test or serum anti-H. pylori antibody. More than one month after the medication, a 13C-urea breath test was conducted to examine the success/failure of the eradication treatment.
###end p 16
###begin title 17
Genotyping
###end title 17
###begin p 18
###xml 51 54 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 96 103 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 131 136 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 148 153 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 208 215 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 304 306 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 324 331 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 429 430 427 428 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 470 471 468 469 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 586 587 584 585 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 620 621 618 619 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 928 929 924 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1356 1357 1316 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1424 1428 1384 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681G</italic>
###xml 1458 1462 1418 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681A</italic>
###xml 1526 1530 1486 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636G</italic>
###xml 1560 1564 1520 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636A</italic>
###xml 1606 1611 1566 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 1622 1627 1582 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 1695 1697 1655 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
DNA was extracted from the buffy coat by a BioRobot(R) EZ1 (QIAGEN Group, Tokyo) for genotyping CYP2C19 G681A (*2) and G636A (*3), IL-1B T-31C, and TNF-A T-1031C. Genotypes were determined separately for the CYP2C19 polymorphisms by polymerase chain reaction with confronting two-pair primers (PCR-CTPP) 22. The primers for CYP2C19 G681A and G636A were *2F1: 5' AGA GCT TGG CAT ATT GTA TCT, *2R1: 5' TAA GTA ATT TGT TAT GGG TTC CC, *2F2: 5' CCA CTA TCA TTG ATT ATT TCC CA, *2R2: 5' TCG ATT CTT GGT GTT CTT TTA C, and *3F1: 5' AAC CAG CTA GGC TGT AAT TGT, *3R1: 5' CTT GGC CTT ACC TGG ATC, *3F2: 5' ATT GTA AGC ACC CCC TGA, *3R2: 5' CAC TGA TCA GGG AGC TAA TG, respectively. The underlined are the bases of the single nucleotide polymorphism. Genomic DNA (30ng to 100ng) was used per 25mul of reaction with 0.18mM dNTPs, 12.5 pmol of each primer, 0.5 units of "AmpliTaq Gold", and 2.5mul GeneAmp 10xPCR Buffer including 15mM MgCl2 (Perkin-Elmer Corp., Foster City, CA). Amplification conditions were 10 minutes of initial denaturation at 95degreesC, followed by 30 cycles of 1 minute at 95degreesC, 1 minute at 59degreesC for G681A and 58degreesC for G636A, and 1 minute at 72degreesC, then a 5 minutes final extension at 72degreesC. The amplified DNA was visualized on a 2% agarose gel with ethidium bromide staining. A representative gel is shown in Fig. 1. The alleles were distinguished as follows: a 131-bp band for the 681G allele and a 105-bp band for 681A allele, with a 191-bp their common band, and a 377-bp band for 636G allele and a 255-bp band for 636A allele, with a 597-bp their common band. IL-1B T-31C and TNF-A T-1031C were genotyped with a duplex PCR-CTPP described previously 23.
###end p 18
###begin title 19
Statistical analysis
###end title 19
###begin p 20
###xml 259 260 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Statistical analysis was performed using STATA Ver. 8 (College Station, TX) statistical software. The Hardy-Weinberg equilibrium, which indicates an absence of discrepancy between genotype and allele frequencies, was checked for the study subjects using a chi2 test. The odds ratios (ORs) and 95% confidence intervals (95% CIs) were adjusted for sex (dichotomous) and age (a continuous variable) using an unconditional logistic regression model.
###end p 20
###begin title 21
3. Results
###end title 21
###begin p 22
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 60 72 <span type="species:ncbi:9606">participants</span>
Table 1 describes the backgrounds of the whole visitors and participants.
###end p 22
###begin p 23
###xml 199 208 199 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> IL-1B</italic>
###xml 446 454 446 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> CYP2C19</italic>
###xml 516 517 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 538 539 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 560 561 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 621 627 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> TNF-A</italic>
###xml 653 654 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 748 755 740 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> TNF-A </italic>
###xml 904 911 896 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 951 955 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*1</italic>
###xml 1002 1007 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*2 </italic>
###xml 1010 1014 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*3</italic>
###xml 1057 1069 1049 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*2*2, *2*3, </italic>
###xml 1072 1076 1064 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*3*3</italic>
###xml 1086 1091 1078 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> *1*1</italic>
###xml 1102 1107 1094 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681GG</italic>
###xml 1112 1117 1104 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636GG</italic>
###xml 1119 1124 1111 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*1*2,</italic>
###xml 1144 1155 1136 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636GG; *1*3</italic>
###xml 1165 1170 1157 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681GG</italic>
###xml 1175 1187 1167 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636GA; *2*2,</italic>
###xml 1197 1202 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681AA</italic>
###xml 1207 1212 1199 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636GG</italic>
###xml 1213 1219 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> *2*3,</italic>
###xml 1229 1234 1221 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681GA</italic>
###xml 1239 1251 1231 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636GA; *3*3,</italic>
###xml 1261 1267 1253 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">681GG </italic>
###xml 1271 1276 1263 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">636AA</italic>
###xml 36 43 <span type="species:ncbi:9606">persons</span>
###xml 181 193 <span type="species:ncbi:9606">participants</span>
###xml 199 208 <span type="species:ncbi:210">H. pylori</span>
###xml 836 847 <span type="species:ncbi:9606">participant</span>
From July 2004 to October 2005, 210 persons visited the center. Among them, 142 were found to be infected, 165 participated in the polymorphism study and LAC were prescribed for 93 participants with H. pylori infection (in fact, 97 were prescribed eradication drug but 4 subjected who failed the eradication by LAC at other clinics were excluded because we dosed them metronidazole instead of clarithromycin). The distribution of the IL-1B T-31C, CYP2C19 G681A and G636A genes were in Hardy-Weinberg equilibrium (chi2=0.83 and p=0.36, chi2=0.72 and p=0.40, chi2=0.54 and p=0.54, respectively), but the distribution of the TNF-A T-1031C gene was not (chi2=4.05, p=0.04). The difference of the distributions between the expected and observed from the TNF-A T-1031C gene was not substantial; 128.3 for 131, 34.4 for 29, and 2.3 for 5. The participant subjects were classified into three groups according to CYP2C19 genotype; rapid metabolizers (RM) with *1*1 genotype, intermediate metabolizers (IM) with *1*2 or *1*3 genotype, and poor metabolizers (PM) with *2*2, *2*3, or *3*3 genotype; *1*1, with the 681GG and 636GG; *1*2, with the 681GA and 636GG; *1*3 with the 681GG and 636GA; *2*2, with the 681AA and 636GG; *2*3, with the 681GA and 636GA; *3*3, with the 681GG and 636AA.
###end p 23
###begin p 24
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 293 304 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B -31CC</italic>
###xml 338 339 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 445 450 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
###xml 519 527 517 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A CT</italic>
###xml 540 542 538 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 42 54 <span type="species:ncbi:9606">participants</span>
Table 2 shows the eradication rate for 67 participants in the polymorphism study who were prescribed LAC and examined for the success/failure of the eradication. The combination of CYP2C19 IM and PM had a significantly high rate relative to RM. The eradication rate was highest for those with IL-1B -31CC but the p value was marginal (chi2=3.78, p=0.05). There were no differences in the eradication rate among those with different genotypes of TNF-A T-1031C. Among the rapid metabolizers, however, the decreased OR of TNF-A CT relative to TT was marginal (OR=0.05, 95% CI, 0.002-1.19). The OR for current and former smokers at the first visit was 0.82 (95% CI, 0.07-10.0) and 0.49 (95% CI, 0.08-3.00), respectively. During the medication, two out of six current smokers quit smoking, three continued smoking, and one did not answer about smoking habit.
###end p 24
###begin title 25
4. Discussion
###end title 25
###begin p 26
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
In the present study, CYP2C19 IM+PM showed a significantly high eradication rate relative to RM. Among the 10 failed, 6 were RM. The IL-1B T-31C polymorphism was associated with the eradication rate. Smoking during non-medication period did not affect the eradication rate. This was the first report on the possible association between the TNF-A polymorphism and the eradication rate among those with RM.
###end p 26
###begin p 27
###xml 47 57 47 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 257 263 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 300 309 300 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 472 482 472 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B -31T</italic>
###xml 495 507 495 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A -1031T</italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 47 56 <span type="species:ncbi:210">H. pylori</span>
###xml 300 309 <span type="species:ncbi:210">H. pylori</span>
The percentage of RM among those infected with H. pylori (31.2%) was similar to that of Japanese populations; by Furuta et al (32.6% of 141 subjects) 14, by Take et al (32.5% of 249 subjects) 15, by Kawabata et al (41.3% of 80 subjects) 16, and by Sugimoto et al (38.1% of 315 controls infected with H. pylori) 24. Those percentages are much lower than those in Europe (81.1% of 143 subjects in Italy 25 and 73.3% of 60 subjects in Germany 26). The allele frequencies for IL-1B -31T (0.536) and TNF-A -1031T (0.871) in this study were also similar to those among Japanese (0.558 of 1,062 chromosomes 27, and 0.835 of 2,742 chromosomes 21, respectively), and lower and higher than that in Italy (0.669 and 0.768 of 1,288 chromosomes, respectively) 28.
###end p 27
###begin p 28
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 284 290 284 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 418 419 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 691 698 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
To date, four studies examined the association of the eradication rate with the CYP2C19 genotypes. Two studies demonstrated non-significant results contrary to ours; in a randomized controlled study of lansoprazole versus rabeprazole for 187 patients with digestive ulcer by Kawabata et al 16, the eradication rate was 73% for 33 RM, 74% for 35 IM, and 83% for 12 PM in the LAC group, and in the study by Miki et al 17, 83% for 12 RM, 85% for 26 IM, and 78% for 9 PM. Although the corresponding association is controversial, our present study confirmed that the RM group relatively resistant to LAC should be treated with a more effective alternative regimen. Accordingly, the genotyping of CYP2C19 before eradication treatment could be useful to avoid the failure of treatment.
###end p 28
###begin p 29
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 135 145 135 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> H. pylori</italic>
###xml 179 190 179 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B -31CC</italic>
###xml 275 276 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 338 345 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 350 355 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 376 378 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 136 145 <span type="species:ncbi:210">H. pylori</span>
The present study indicated that the polymorphism of IL-1B T-31C tightly linked with C-511T is one of the determinants on the result of H. pylori eradication. Among the RM group, IL-1B -31CC tended to show the highest eradication rate but the p value was not significant (chi2=1.60, p=0.21). Although the association with combinations of CYP2C19 and IL-1B C-511T was reported 15, our data did not reach significance, probably due to the small number of subjects analyzed.
###end p 29
###begin p 30
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A </italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A </italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A </italic>
###xml 293 299 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863 A</italic>
###xml 350 352 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sup>
###xml 386 399 378 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A -1031TT</italic>
###xml 431 440 423 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 472 486 464 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> TNF-A -1031TT</italic>
###xml 555 557 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 611 625 599 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> TNF-A -1031CT</italic>
###xml 687 696 675 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 431 440 <span type="species:ncbi:210">H. pylori</span>
###xml 687 696 <span type="species:ncbi:210">H. pylori</span>
TNF-A T-1031C did not provide useful information to predict the result of the eradication treatment. But among the RM group, TNF-A T-1031C was useful as the indication of the success/failure of the eradication. TNF-A C-863A polymorphism linked tightly to T-1031C affects TNF-alpha expression; -863 A was associated with a lower serum TNF-alpha level.29 Previously we have reported that TNF-A -1031TT was associated with persistent H. pylori infection and hypothesized that TNF-A -1031TT produces the high level of TNF-alpha, resulting in low gastric acid 21. This study also indicated that those with the RM and TNF-A -1031CT genotype could not suppress gastric acid enough to eradicate H. pylori. Because this result was based on the small numbers, studies of a larger size are needed to confirm our finding.
###end p 30
###begin p 31
###xml 40 49 40 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 343 353 343 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 447 455 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> CYP2C19</italic>
###xml 486 492 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> IL-1B</italic>
###xml 551 559 551 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> CYP2C19</italic>
###xml 601 615 601 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> IL-1B -511CC </italic>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 643 649 643 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> TNF-A</italic>
###xml 710 720 710 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> H. pylori</italic>
###xml 40 49 <span type="species:ncbi:210">H. pylori</span>
###xml 343 352 <span type="species:ncbi:210">H. pylori</span>
###xml 711 720 <span type="species:ncbi:210">H. pylori</span>
The problem of clarithromycin-resistant H. pylori is substantial in the eradication, but we could not determine the drug resistance because endoscopy was not conducted in our clinic. This is one of the limitations of this study. It was reported that the eradication rate was quite low among the RM group infected with clarithromycin-resistant H. pylori 14. Take et al reported that in a mulitivariate analysis, susceptibility to clarithromycin and CYP2C19 were significant factors, with IL-1B C-511T and smoking not significant, but the association of CYP2C19 genotype was marked only among those with IL-1B -511CC 15. The relation between the TNF-A genotype and the eradication rate according to the status of H. pylori drug resistance remains to be elucidated.
###end p 31
###begin p 32
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 341 350 341 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 341 350 <span type="species:ncbi:210">H. pylori</span>
It has been well documented that smokers had a lower success probability of the eradication 30-32. On the other hand, smokers who quit smoking during the medication reportedly had a higher eradication rate 32. We strongly recommended to quit smoking during the medication, so two quit smoking at least during the medication and succeeded in H. pylori eradication. Since the smokers during the medication were four at most, eradication rate for smokers could not be estimated with an enough statistical power.
###end p 32
###begin p 33
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> CYP2C19</italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 371 383 371 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A -1031C</italic>
###xml 602 609 602 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 582 594 <span type="species:ncbi:9606">participants</span>
In conclusion, the present study confirmed the low eradication rate among the RM who were treated with LAC. The reproduced finding provides evidence that the CYP2C19 and IL-1B genotype are useful to predict the success of the treatment. For the RM group, alternative regimens expected to be with a higher eradication rate will be recommended especially to those with the TNF-A -1031C allele. Further biological investigation will be required to elucidate the association of these polymorphisms and the eradication rate. Based on the finding, we began in November 2005 to inform the participants of the CYP2C19 genotype to recommend another triple therapy (rabeprazole, metronidazole, and amoxicillin) for those with RM 16,33.
###end p 33
###begin p 34
The authors are grateful to Ms. Yoko Mitsuda and Ms. Mayumi Kato for their technical assistance. This work was supported in part by a Grant-in-Aid for Cancer Research (17Shitei-6) from the Ministry of Health, Labour and Welfare of Japan.
###end p 34
###begin article-title 35
###xml 35 54 35 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 35 54 <span type="species:ncbi:210">Helicobacter pylori</span>
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease
###end article-title 35
###begin article-title 36
###xml 15 34 15 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 15 34 <span type="species:ncbi:210">Helicobacter pylori</span>
Infection with Helicobacter pylori
###end article-title 36
###begin article-title 37
###xml 51 70 51 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 51 70 <span type="species:ncbi:210">Helicobacter pylori</span>
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication
###end article-title 37
###begin article-title 38
###xml 12 33 12 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> Helicobacter pylori </italic>
###xml 13 32 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Effective of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura
###end article-title 38
###begin article-title 39
###xml 10 29 10 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 10 29 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura - a randomized controlled trial
###end article-title 39
###begin article-title 40
###xml 10 30 10 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 10 29 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria
###end article-title 40
###begin article-title 41
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature
###end article-title 41
###begin article-title 42
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori infection and infertility
###end article-title 42
###begin article-title 43
###xml 10 29 10 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 10 29 <span type="species:ncbi:210">Helicobacter pylori</span>
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
###end article-title 43
###begin article-title 44
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 37 56 37 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 0 9 <span type="species:ncbi:210">H. pylori</span>
###xml 37 56 <span type="species:ncbi:210">Helicobacter pylori</span>
H. pylori-Gastric Cancer Task Force. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique
###end article-title 44
###begin article-title 45
###xml 34 54 34 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 34 53 <span type="species:ncbi:210">Helicobacter pylori</span>
A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial
###end article-title 45
###begin article-title 46
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori eradication reduces medical care costs: a community-based study
###end article-title 46
###begin article-title 47
###xml 121 140 121 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 121 140 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients
###end article-title 47
###begin article-title 48
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19 </italic>
###xml 38 57 38 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H pylori</italic>
###xml 38 57 <span type="species:ncbi:210">Helicobacter pylori</span>
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection
###end article-title 48
###begin article-title 49
###xml 137 156 134 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 137 156 <span type="species:ncbi:210">Helicobacter pylori</span>
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection
###end article-title 49
###begin article-title 50
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19 </italic>
###xml 129 148 129 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 129 148 <span type="species:ncbi:210">Helicobacter pylori</span>
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin
###end article-title 50
###begin article-title 51
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 94 114 94 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 94 113 <span type="species:ncbi:210">Helicobacter pylori</span>
Impact of clarithromycin resistence and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan
###end article-title 51
###begin article-title 52
###xml 16 30 16 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">interleukin-1B</italic>
###xml 64 84 64 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 64 83 <span type="species:ncbi:210">Helicobacter pylori</span>
Polymorphism of interleukin-1B affects the eradication rates of Helicobacter pylori by triple therapy
###end article-title 52
###begin article-title 53
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Interleukin 1</italic>
###xml 52 71 52 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 52 71 <span type="species:ncbi:210">Helicobacter pylori</span>
Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection
###end article-title 53
###begin article-title 54
###xml 87 93 <span type="species:ncbi:9986">rabbit</span>
Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways
###end article-title 54
###begin article-title 55
###xml 14 25 14 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A-857TT</italic>
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031TT</italic>
###xml 67 86 67 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 67 86 <span type="species:ncbi:210">Helicobacter pylori</span>
Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes
###end article-title 55
###begin article-title 56
Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping
###end article-title 56
###begin article-title 57
###xml 35 45 35 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2E1 Rsa</italic>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-2</italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-A</italic>
Use of duplex PCR-CTPP methods for CYP2E1 RsaI/IL-2 T-330G and IL-1B C-31T/TNF-A T-1031C polymorphisms
###end article-title 57
###begin article-title 58
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
###xml 117 136 117 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 117 136 <span type="species:ncbi:210">Helicobacter pylori</span>
Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection
###end article-title 58
###begin article-title 59
###xml 50 69 50 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 50 69 <span type="species:ncbi:210">Helicobacter pylori</span>
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management
###end article-title 59
###begin article-title 60
Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19
###end article-title 60
###begin article-title 61
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 40 54 40 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">interleukin 1B</italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori seropositivity, the interleukin 1B polymorphism, and smoking among first-visit outpatients
###end article-title 61
###begin article-title 62
###xml 60 79 60 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 60 79 <span type="species:ncbi:210">Helicobacter pylori</span>
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome
###end article-title 62
###begin article-title 63
A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha
###end article-title 63
###begin article-title 64
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 69 78 <span type="species:ncbi:210">H. pylori</span>
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin and clarithromycin
###end article-title 64
###begin article-title 65
###xml 25 44 25 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 25 44 <span type="species:ncbi:210">Helicobacter pylori</span>
Predictors of failure of Helicobacter pylori eradication with the standard "Maastricht triple therapy
###end article-title 65
###begin article-title 66
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Le </italic>
###xml 74 83 74 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 74 83 <span type="species:ncbi:210">H. pylori</span>
Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin
###end article-title 66
###begin article-title 67
Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers
###end article-title 67
###begin title 68
Figures and Tables
###end title 68
###begin p 69
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C19</italic>
The agarose gel electrophoresis for polymorphism at G681A and G636A of CYP2C19 by PCR with confronting.
###end p 69
###begin p 70
###xml 40 52 <span type="species:ncbi:9606">participants</span>
Characteristics of the visitors and the participants in the polymorphism study
###end p 70
###begin p 71
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 142 151 142 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 142 151 <span type="species:ncbi:210">H. pylori</span>
a The information on the status of smoking was not available for one subject. b Three subjects among visitors did not take the examination on H. pylori infection. c One subject was not genotyped
###end p 71
###begin p 72
###xml 60 72 <span type="species:ncbi:9606">participants</span>
The rate and odds ratios (ORs) of the eradication among the participants in the polymorphism study who were prescribed LAC and examined for the success/failure of the eradication.
###end p 72
###begin p 73
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </sup>
###xml 150 152 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c </sup>
###xml 188 189 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 196 199 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> d </sup>
###xml 249 255 247 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e,f,g </sup>
###xml 287 288 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2 14 <span type="species:ncbi:9606">participants</span>
###xml 209 221 <span type="species:ncbi:9606">participants</span>
a participants in the polymorphism study who were prescribed LAC and examined for the success/failure of the eradication. b adjusted for sex and age. c p=0.012 for 2 by 3 table using a chi2 test.  d Among the participants with the rapid metabolism. e,f,g Compared with reference by a chi2 test, the p values were 0.05, 0.21 and 0.61, respectively
###end p 73

